GO Annotation
| Category | Term ID | Term description |
|---|---|---|
| Process | GO:0001558 | Regulation of cell growth |
| Process | GO:0006915 | Apoptotic process |
| Process | GO:0006929 | Substrate-dependent cell migration |
| Process | GO:0006931 | Substrate-dependent cell migration, cell attachment to substrate |
| Process | GO:0007154 | Cell communication |
| Process | GO:0007155 | Cell adhesion |
| Process | GO:0007165 | Signal transduction |
| Process | GO:0007166 | Cell surface receptor signaling pathway |
| Process | GO:0008219 | Cell death |
| Process | GO:0008361 | Regulation of cell size |
| Process | GO:0009966 | Regulation of signal transduction |
| Process | GO:0009967 | Positive regulation of signal transduction |
| Process | GO:0009987 | Cellular process |
| Process | GO:0010646 | Regulation of cell communication |
| Process | GO:0010647 | Positive regulation of cell communication |
| Process | GO:0010720 | Positive regulation of cell development |
| Process | GO:0010941 | Regulation of cell death |
| Process | GO:0010942 | Positive regulation of cell death |
| Process | GO:0010975 | Regulation of neuron projection development |
| Process | GO:0012501 | Programmed cell death |
| Process | GO:0016043 | Cellular component organization |
| Process | GO:0016477 | Cell migration |
| Process | GO:0022603 | Regulation of anatomical structure morphogenesis |
| Process | GO:0023051 | Regulation of signaling |
| Process | GO:0023052 | Signaling |
| Process | GO:0023056 | Positive regulation of signaling |
| Process | GO:0030307 | Positive regulation of cell growth |
| Process | GO:0030516 | Regulation of axon extension |
| Process | GO:0031344 | Regulation of cell projection organization |
| Process | GO:0031346 | Positive regulation of cell projection organization |
| Process | GO:0031589 | Cell-substrate adhesion |
| Process | GO:0032535 | Regulation of cellular component size |
| Process | GO:0040008 | Regulation of growth |
| Process | GO:0042981 | Regulation of apoptotic process |
| Process | GO:0043065 | Positive regulation of apoptotic process |
| Process | GO:0043067 | Regulation of programmed cell death |
| Process | GO:0043068 | Positive regulation of programmed cell death |
| Process | GO:0045595 | Regulation of cell differentiation |
| Process | GO:0045597 | Positive regulation of cell differentiation |
| Process | GO:0045765 | Regulation of angiogenesis |
| Process | GO:0045773 | Positive regulation of axon extension |
| Process | GO:0045927 | Positive regulation of growth |
| Process | GO:0048518 | Positive regulation of biological process |
| Process | GO:0048522 | Positive regulation of cellular process |
| Process | GO:0048583 | Regulation of response to stimulus |
| Process | GO:0048584 | Positive regulation of response to stimulus |
| Process | GO:0048638 | Regulation of developmental growth |
| Process | GO:0048639 | Positive regulation of developmental growth |
| Process | GO:0048870 | Cell motility |
| Process | GO:0050767 | Regulation of neurogenesis |
| Process | GO:0050769 | Positive regulation of neurogenesis |
| Process | GO:0050770 | Regulation of axonogenesis |
| Process | GO:0050772 | Positive regulation of axonogenesis |
| Process | GO:0050789 | Regulation of biological process |
| Process | GO:0050793 | Regulation of developmental process |
| Process | GO:0050794 | Regulation of cellular process |
| Process | GO:0050896 | Response to stimulus |
| Process | GO:0051094 | Positive regulation of developmental process |
| Process | GO:0051128 | Regulation of cellular component organization |
| Process | GO:0051130 | Positive regulation of cellular component organization |
| Process | GO:0051239 | Regulation of multicellular organismal process |
| Process | GO:0051240 | Positive regulation of multicellular organismal process |
| Process | GO:0051716 | Cellular response to stimulus |
| Process | GO:0051960 | Regulation of nervous system development |
| Process | GO:0051962 | Positive regulation of nervous system development |
| Process | GO:0060284 | Regulation of cell development |
| Process | GO:0061041 | Regulation of wound healing |
| Process | GO:0061387 | Regulation of extent of cell growth |
| Process | GO:0065007 | Biological regulation |
| Process | GO:0065008 | Regulation of biological quality |
| Process | GO:0071840 | Cellular component organization or biogenesis |
| Process | GO:0080134 | Regulation of response to stress |
| Process | GO:0090066 | Regulation of anatomical structure size |
| Process | GO:0097190 | Apoptotic signaling pathway |
| Process | GO:0097191 | Extrinsic apoptotic signaling pathway |
| Process | GO:0120035 | Regulation of plasma membrane bounded cell projection organization |
| Process | GO:1901342 | Regulation of vasculature development |
| Process | GO:1903034 | Regulation of response to wounding |
| Process | GO:2000026 | Regulation of multicellular organismal development |
| Process | GO:2001233 | Regulation of apoptotic signaling pathway |
| Process | GO:2001235 | Positive regulation of apoptotic signaling pathway |
| Process | GO:2001236 | Regulation of extrinsic apoptotic signaling pathway |
| Process | GO:2001238 | Positive regulation of extrinsic apoptotic signaling pathway |
| Component | GO:0001726 | Ruffle |
| Component | GO:0005886 | Plasma membrane |
| Component | GO:0009986 | Cell surface |
| Component | GO:0016020 | Membrane |
| Component | GO:0031252 | Cell leading edge |
| Component | GO:0042995 | Cell projection |
| Component | GO:0071944 | Cell periphery |
| Component | GO:0110165 | Cellular anatomical entity |
| Component | GO:0120025 | Plasma membrane bounded cell projection |
Pathway annotation
| Category | Term ID | Term description |
|---|---|---|
| RCTM | RNO-1280215 | Cytokine Signaling in Immune system |
| RCTM | RNO-168256 | Immune System |
| RCTM | RNO-5668541 | TNFR2 non-canonical NF-kB pathway |
| RCTM | RNO-5676594 | TNF receptor superfamily (TNFSF) members mediating non-canonical NF-kB pathway |
| KEGG | rno04060 | Cytokine-cytokine receptor interaction |
Expression profile of Tnfrsf12a in omics data
| ID | GSE100499 |
| Title | Exploring acupuncture mechanism in preconditioning of IRI |
| Organism | Rattus norvegicus |
| GSM | Sample info | Characteristics | Value |
|---|---|---|---|
| GSM2685201 | MX1 | tissue: Myocardium gender: male | 11.692201 |
| GSM2685202 | MX2 | tissue: Myocardium gender: female | 12.154091 |
| GSM2685203 | MX3 | tissue: Myocardium gender: female | 11.988056 |
| GSM2685204 | MX4 | tissue: Myocardium gender: male | 11.365778 |
| GSM2685205 | DZ1 | tissue: Myocardium gender: male | 10.680221 |
| GSM2685206 | DZ2 | tissue: Myocardium gender: male | 10.806126 |
| GSM2685207 | DZ3 | tissue: Myocardium gender: female | 11.273918 |
| GSM2685208 | DZ4 | tissue: Myocardium gender: female | 11.327045 |
| GSM2685209 | JJ1 | tissue: Myocardium gender: male | 11.418333 |
| GSM2685210 | JJ2 | tissue: Myocardium gender: female | 11.573319 |
| GSM2685211 | JJ3 | tissue: Myocardium gender: female | 12.138887 |
| GSM2685212 | JJ4 | tissue: Myocardium gender: male | 11.304367 |
| GSM2685213 | NG1 | tissue: Myocardium gender: male | 11.852204 |
| GSM2685214 | NG2 | tissue: Myocardium gender: female | 11.579657 |
| GSM2685215 | NG3 | tissue: Myocardium gender: male | 11.805275 |
| GSM2685216 | NG4 | tissue: Myocardium gender: female | 11.275308 |
| GSM2685217 | YL1 | tissue: Myocardium gender: male | 11.319839 |
| GSM2685218 | YL2 | tissue: Myocardium gender: male | 11.732915 |
| GSM2685219 | YL3 | tissue: Myocardium gender: female | 12.084402 |
| GSM2685220 | YL4 | tissue: Myocardium gender: female | 11.660517 |
| GSM2685221 | QC1 | tissue: Myocardium gender: male | 12.551325 |
| GSM2685222 | QC2 | tissue: Myocardium gender: male | 12.696988 |
| GSM2685223 | QC3 | tissue: Myocardium gender: female | 12.885718 |
| GSM2685224 | QC4 | tissue: Myocardium gender: female | 12.129354 |
| ID | GSE136833 |
| Title | Effects of lidocaine on the expression of rat spinal cord |
| Organism | Rattus norvegicus |
| GSM | Sample info | Characteristics | Value |
|---|---|---|---|
| GSM4058984 | Control_1 | strain: Sprague-Dawley tissue: Lumbar segment of spinal cord | 5.679776197 |
| GSM4058985 | Control_2 | strain: Sprague-Dawley tissue: Lumbar segment of spinal cord | 5.82408246 |
| GSM4058986 | Control_3 | strain: Sprague-Dawley tissue: Lumbar segment of spinal cord | 5.557713886 |
| GSM4058987 | Lidocaine_1 | strain: Sprague-Dawley tissue: Lumbar segment of spinal cord | 6.59681082 |
| GSM4058988 | Lidocaine_2 | strain: Sprague-Dawley tissue: Lumbar segment of spinal cord | 6.814445924 |
| GSM4058989 | Lidocaine_3 | strain: Sprague-Dawley tissue: Lumbar segment of spinal cord | 7.03138582 |
| ID | GSE138454 |
| Title | Impact of inflammation on hepatic subcellular energetics in anesthetized rats |
| Organism | Rattus norvegicus |
| GSM | Sample info | Characteristics | Value |
|---|---|---|---|
| GSM4108997 | Sample 1 Isoflurane sepsis | anesthetic background: Isoflurane strain: Sprague-Dawley age: 10 weeks old sepsis/control: sepsis gender: male | 1333.0 |
| GSM4108998 | Sample 2 Isoflurane sepsis | anesthetic background: Isoflurane strain: Sprague-Dawley age: 10 weeks old sepsis/control: sepsis gender: male | 1546.0 |
| GSM4108999 | Sample 3 Isoflurane sepsis | anesthetic background: Isoflurane strain: Sprague-Dawley age: 10 weeks old sepsis/control: sepsis gender: male | 2552.0 |
| GSM4109000 | Sample 4 Isoflurane sepsis | anesthetic background: Isoflurane strain: Sprague-Dawley age: 10 weeks old sepsis/control: sepsis gender: male | 1585.0 |
| GSM4109001 | Sample 5 Isoflurane control | anesthetic background: Isoflurane strain: Sprague-Dawley age: 10 weeks old sepsis/control: control gender: male | 930.0 |
| GSM4109002 | Sample 6 Isoflurane control | anesthetic background: Isoflurane strain: Sprague-Dawley age: 10 weeks old sepsis/control: control gender: male | 781.0 |
| GSM4109003 | Sample 7 Isoflurane control | anesthetic background: Isoflurane strain: Sprague-Dawley age: 10 weeks old sepsis/control: control gender: male | 624.0 |
| GSM4109004 | Sample 8 Isoflurane control | anesthetic background: Isoflurane strain: Sprague-Dawley age: 10 weeks old sepsis/control: control gender: male | 1815.0 |
| GSM4109005 | Sample9 Propofol sepsis | anesthetic background: Propofol strain: Sprague-Dawley age: 10 weeks old sepsis/control: sepsis gender: male | 688.0 |
| GSM4109006 | Sample10 Propofol sepsis | anesthetic background: Propofol strain: Sprague-Dawley age: 10 weeks old sepsis/control: sepsis gender: male | 1118.0 |
| GSM4109007 | Sample11 Propofol sepsis | anesthetic background: Propofol strain: Sprague-Dawley age: 10 weeks old sepsis/control: sepsis gender: male | 847.0 |
| GSM4109008 | Sample12 Propofol sepsis | anesthetic background: Propofol strain: Sprague-Dawley age: 10 weeks old sepsis/control: sepsis gender: male | 1351.0 |
| GSM4109009 | Sample13 Propofol control | anesthetic background: Propofol strain: Sprague-Dawley age: 10 weeks old sepsis/control: control gender: male | 534.0 |
| GSM4109010 | Sample14 Propofol control | anesthetic background: Propofol strain: Sprague-Dawley age: 10 weeks old sepsis/control: control gender: male | 373.0 |
| GSM4109011 | Sample 15 Propofol control | anesthetic background: Propofol strain: Sprague-Dawley age: 10 weeks old sepsis/control: control gender: male | 681.0 |
| GSM4109012 | Sample16 Propofol control | anesthetic background: Propofol strain: Sprague-Dawley age: 10 weeks old sepsis/control: control gender: male | 387.0 |
| ID | GSE139220 |
| Title | Expression data from sevoflurane anesthesia treated rat |
| Organism | Rattus norvegicus |
| GSM | Sample info | Characteristics | Value |
|---|---|---|---|
| GSM4134285 | Brain_Control_rep1 | strain: Sprague-Dawley age: 18-month old treatment: control tissue: hippocampus | 6.315789 |
| GSM4134286 | Brain_Control_rep2 | strain: Sprague-Dawley age: 18-month old treatment: control tissue: hippocampus | 6.505896 |
| GSM4134287 | Brain_Control_rep3 | strain: Sprague-Dawley age: 18-month old treatment: control tissue: hippocampus | 6.35081 |
| GSM4134288 | Brain_Sevoflurane_rep1 | strain: Sprague-Dawley age: 18-month old treatment: sevoflurane anesthesia tissue: hippocampus | 6.493801 |
| GSM4134289 | Brain_Sevoflurane_rep2 | strain: Sprague-Dawley age: 18-month old treatment: sevoflurane anesthesia tissue: hippocampus | 6.48641 |
| GSM4134290 | Brain_Sevoflurane_rep3 | strain: Sprague-Dawley age: 18-month old treatment: sevoflurane anesthesia tissue: hippocampus | 6.27042 |
| ID | GSE143895 |
| Title | GPR160 de-orphanization reveals critical roles in neuropathic pain in rodents |
| Organism | Rattus norvegicus |
| GSM | Sample info | Characteristics | Value |
|---|---|---|---|
| GSM4276356 | dhsc01 | strain: Sprague Dawley tissue: DHSC treatment: CCI | 11.136 |
| GSM4276357 | dhsc03 | strain: Sprague Dawley tissue: DHSC treatment: CCI | 9.769 |
| GSM4276358 | dhsc05 | strain: Sprague Dawley tissue: DHSC treatment: CCI | 9.702 |
| GSM4276359 | dhsc13 | strain: Sprague Dawley tissue: DHSC treatment: SHAM | 9.217 |
| GSM4276360 | dhsc15 | strain: Sprague Dawley tissue: DHSC treatment: SHAM | 8.414 |
| ID | GSE157924 |
| Title | Regulation of acupuncture on genes in brain stem |
| Organism | Rattus norvegicus |
| GSM | Sample info | Characteristics | Value |
|---|---|---|---|
| GSM4780973 | Rattus_JSSZ(Sham) | tissue: Rattus brainstem of modeling treatment: Sham | 7.599526935 |
| GSM4780974 | Rattus_JXZ(Hand Acu) | tissue: Rattus brainstem of modeling treatment: Hand Acu | 7.590238872 |
| GSM4780975 | Rattus_MXZ(TBI) | tissue: Rattus brainstem of modeling treatment: TBI | 8.24077898 |
| ID | GSE1779 |
| Title | Effect of Isoflurane and LTM on basolateral amygdala |
| Organism | Rattus norvegicus |
| GSM | Sample info | Characteristics | Value |
|---|---|---|---|
| GSM30790 | baseline control 01 | male, 275-300g | 86.4 |
| GSM30791 | baseline control 02 | male, 275-300g | 131.3 |
| GSM30792 | baseline control 03 | male, 275-300g | 110.8 |
| GSM30793 | baseline control 04 | male, 275-300g | 97.2 |
| GSM30794 | baseline control 05 | male, 275-300g | 71.5 |
| GSM30795 | baseline control 06 | male, 275-300g | 67.2 |
| GSM30796 | baseline control 07 | male, 275-300g | 59.6 |
| GSM30797 | baseline control 08 | male, 275-300g | 74.2 |
| GSM30798 | baseline control 09 | male, 275-300g | 98.7 |
| GSM30799 | pain 01 | 86.1 | |
| GSM30800 | pain 02 | 97.9 | |
| GSM30801 | pain 03 | 184.2 | |
| GSM30802 | pain 04 | 96.9 | |
| GSM30803 | pain 05 | 56.3 | |
| GSM30804 | FC 01 | 96.4 | |
| GSM30805 | FC 02 | 111.1 | |
| GSM30806 | FC 03 | 65.8 | |
| GSM30807 | FC 04 | 72.5 | |
| GSM30808 | FC 05 | 89.1 | |
| GSM30809 | IFC 01 | 95.0 | |
| GSM30810 | IFC 02 | 78.2 | |
| GSM30811 | IFC 03 | 109.9 | |
| GSM30812 | IFC 04 | 89.0 | |
| GSM30813 | IFC 05 | 106.9 | |
| GSM99800 | isoflurane 01 | male, 275-300g | 98.2 |
| GSM99801 | isoflurane 02 | male, 275-300g | 108.8 |
| GSM99802 | isoflurane 03 | male, 275-300g | 133.0 |
| GSM99803 | isoflurane 04 | male, 275-300g | 87.6 |
| GSM99804 | isoflurane 05 | male, 275-300g | 98.5 |
| ID | GSE190472 |
| Title | Study on VEGF regulation mechanism of acupuncture improving endometrial receptivity in IVF-ET |
| Organism | Rattus norvegicus |
| GSM | Sample info | Characteristics | Value |
|---|---|---|---|
| GSM5724271 | model 21 | Sex: female tissue: Uterine tissue condition: model | 82.963 |
| GSM5724272 | model 22 | Sex: female tissue: Uterine tissue condition: model | 81.1159 |
| GSM5724273 | model 23 | Sex: female tissue: Uterine tissue condition: model | 93.5515 |
| GSM5724274 | treatment31 | Sex: female tissue: Uterine tissue condition: treatment | 81.8371 |
| GSM5724275 | treatment32 | Sex: female tissue: Uterine tissue condition: treatment | 218.8813 |
| GSM5724276 | treatment33 | Sex: female tissue: Uterine tissue condition: treatment | 74.7679 |
| GSM5724277 | control 41 | Sex: female tissue: Uterine tissue condition: control | 109.3028 |
| GSM5724278 | control 42 | Sex: female tissue: Uterine tissue condition: control | 87.3029 |
| GSM5724279 | control 43 | Sex: female tissue: Uterine tissue condition: control | 72.4747 |
| ID | GSE192399 |
| Title | Gene expression of brain regions activated by sevoflurane and propofol |
| Organism | Rattus norvegicus |
| GSM | Sample info | Characteristics | Value |
|---|---|---|---|
| GSM5746332 | LHb, Sevoflurane, 60mins | brain region: the lateral habenula (LHb) treatment: Sevoflurane | 6.81522 |
| GSM5746333 | LHb, O2, 60mins | brain region: the lateral habenula (LHb) treatment: O2 | 5.75123 |
| GSM5746334 | MHb, Sevoflurane, 60mins | brain region: the medial habenula (MHb) treatment: Sevoflurane | 5.60029 |
| GSM5746335 | MHb, O2, 60mins | brain region: the medial habenula (MHb) treatment: O2 | 5.93806 |
| GSM5746336 | Sol, Sevoflurane, 60mins | brain region: the solitary nucleus (Sol) treatment: Sevoflurane | 5.92144 |
| GSM5746337 | Sol, O2, 60mins | brain region: the solitary nucleus (Sol) treatment: O2 | 6.11775 |
| GSM5746338 | Mve, Sevoflurane, 60mins | brain region: the medial vestibular nucleus (MVe) treatment: Sevoflurane | 6.83955 |
| GSM5746339 | Mve, O2, 60mins | brain region: the medial vestibular nucleus (MVe) treatment: O2 | 6.25288 |
| GSM5746340 | LHb, Propofol, 60mins | brain region: the lateral habenula (LHb) treatment: Propofol | 5.81564 |
| GSM5746341 | LHb, Intralipos, 60mins | brain region: the lateral habenula (LHb) treatment: Intralipos | 5.28094 |
| GSM5746342 | MHb, Propofol, 60mins | brain region: the medial habenula (MHb) treatment: Propofol | 5.26735 |
| GSM5746343 | MHb, Intralipos, 60mins | brain region: the medial habenula (MHb) treatment: Intralipos | 5.2323 |
| GSM5746344 | Sol, Propofol, 60mins | brain region: the solitary nucleus (Sol) treatment: Propofol | 5.10878 |
| GSM5746345 | Sol, Intralipos, 60mins | brain region: the solitary nucleus (Sol) treatment: Intralipos | 5.38626 |
| GSM5746346 | MVe, Propofol, 60mins | brain region: the medial vestibular nucleus (MVe) treatment: Propofol | 5.84792 |
| GSM5746347 | MVe, Intralipos, 60mins | brain region: the medial vestibular nucleus (MVe) treatment: Intralipos | 5.51474 |
| ID | GSE205202 |
| Title | Hepatic responses of mice and rats to equivalent acetaminophen (APAP) insult [rat] |
| Organism | Rattus norvegicus |
| GSM | Sample info | Characteristics | Value |
|---|---|---|---|
| GSM6208507 | Rat_Baseline_0h_1 | tissue: liver strain: Sprague-Dawley Sex: male treatment: Untreated hours after treatment: 0 | 6.271654 |
| GSM6208508 | Rat_Baseline_0h_2 | tissue: liver strain: Sprague-Dawley Sex: male treatment: Untreated hours after treatment: 0 | 6.38583 |
| GSM6208509 | Rat_Baseline_0h_3 | tissue: liver strain: Sprague-Dawley Sex: male treatment: Untreated hours after treatment: 0 | 6.311639 |
| GSM6208510 | Rat_Baseline_0h_4 | tissue: liver strain: Sprague-Dawley Sex: male treatment: Untreated hours after treatment: 0 | 6.230665 |
| GSM6208511 | Rat_Baseline_0h_5 | tissue: liver strain: Sprague-Dawley Sex: male treatment: Untreated hours after treatment: 0 | 6.369902 |
| GSM6208512 | Rat_Vehicle_03h_1 | tissue: liver strain: Sprague-Dawley Sex: male treatment: Vehicle (1% [w/v] hydroxyethylcellulose, o.g.) hours after treatment: 3 | 6.332466 |
| GSM6208513 | Rat_Vehicle_03h_2 | tissue: liver strain: Sprague-Dawley Sex: male treatment: Vehicle (1% [w/v] hydroxyethylcellulose, o.g.) hours after treatment: 3 | 6.915327 |
| GSM6208514 | Rat_Vehicle_03h_3 | tissue: liver strain: Sprague-Dawley Sex: male treatment: Vehicle (1% [w/v] hydroxyethylcellulose, o.g.) hours after treatment: 3 | 6.462932 |
| GSM6208515 | Rat_Vehicle_03h_4 | tissue: liver strain: Sprague-Dawley Sex: male treatment: Vehicle (1% [w/v] hydroxyethylcellulose, o.g.) hours after treatment: 3 | 7.070388 |
| GSM6208516 | Rat_Vehicle_03h_5 | tissue: liver strain: Sprague-Dawley Sex: male treatment: Vehicle (1% [w/v] hydroxyethylcellulose, o.g.) hours after treatment: 3 | 6.777471 |
| GSM6208517 | Rat_Vehicle_06h_1 | tissue: liver strain: Sprague-Dawley Sex: male treatment: Vehicle (1% [w/v] hydroxyethylcellulose, o.g.) hours after treatment: 6 | 6.322388 |
| GSM6208518 | Rat_Vehicle_06h_2 | tissue: liver strain: Sprague-Dawley Sex: male treatment: Vehicle (1% [w/v] hydroxyethylcellulose, o.g.) hours after treatment: 6 | 6.011232 |
| GSM6208519 | Rat_Vehicle_06h_3 | tissue: liver strain: Sprague-Dawley Sex: male treatment: Vehicle (1% [w/v] hydroxyethylcellulose, o.g.) hours after treatment: 6 | 6.300171 |
| GSM6208520 | Rat_Vehicle_06h_4 | tissue: liver strain: Sprague-Dawley Sex: male treatment: Vehicle (1% [w/v] hydroxyethylcellulose, o.g.) hours after treatment: 6 | 6.03477 |
| GSM6208521 | Rat_Vehicle_06h_5 | tissue: liver strain: Sprague-Dawley Sex: male treatment: Vehicle (1% [w/v] hydroxyethylcellulose, o.g.) hours after treatment: 6 | 6.235367 |
| GSM6208522 | Rat_Vehicle_09h_1 | tissue: liver strain: Sprague-Dawley Sex: male treatment: Vehicle (1% [w/v] hydroxyethylcellulose, o.g.) hours after treatment: 9 | 6.25995 |
| GSM6208523 | Rat_Vehicle_09h_2 | tissue: liver strain: Sprague-Dawley Sex: male treatment: Vehicle (1% [w/v] hydroxyethylcellulose, o.g.) hours after treatment: 9 | 6.489433 |
| GSM6208524 | Rat_Vehicle_09h_3 | tissue: liver strain: Sprague-Dawley Sex: male treatment: Vehicle (1% [w/v] hydroxyethylcellulose, o.g.) hours after treatment: 9 | 6.11824 |
| GSM6208525 | Rat_Vehicle_09h_4 | tissue: liver strain: Sprague-Dawley Sex: male treatment: Vehicle (1% [w/v] hydroxyethylcellulose, o.g.) hours after treatment: 9 | 6.164591 |
| GSM6208526 | Rat_Vehicle_09h_5 | tissue: liver strain: Sprague-Dawley Sex: male treatment: Vehicle (1% [w/v] hydroxyethylcellulose, o.g.) hours after treatment: 9 | 6.154299 |
| GSM6208527 | Rat_Vehicle_24h_1 | tissue: liver strain: Sprague-Dawley Sex: male treatment: Vehicle (1% [w/v] hydroxyethylcellulose, o.g.) hours after treatment: 24 | 5.93912 |
| GSM6208528 | Rat_Vehicle_24h_2 | tissue: liver strain: Sprague-Dawley Sex: male treatment: Vehicle (1% [w/v] hydroxyethylcellulose, o.g.) hours after treatment: 24 | 6.133297 |
| GSM6208529 | Rat_Vehicle_24h_3 | tissue: liver strain: Sprague-Dawley Sex: male treatment: Vehicle (1% [w/v] hydroxyethylcellulose, o.g.) hours after treatment: 24 | 6.153792 |
| GSM6208530 | Rat_Vehicle_24h_4 | tissue: liver strain: Sprague-Dawley Sex: male treatment: Vehicle (1% [w/v] hydroxyethylcellulose, o.g.) hours after treatment: 24 | 6.161749 |
| GSM6208531 | Rat_Vehicle_24h_5 | tissue: liver strain: Sprague-Dawley Sex: male treatment: Vehicle (1% [w/v] hydroxyethylcellulose, o.g.) hours after treatment: 24 | 5.963006 |
| GSM6208532 | Rat_APAP_03h_1 | tissue: liver strain: Sprague-Dawley Sex: male treatment: 1000 mg/kg acetamnophen (o.g.) hours after treatment: 3 | 8.680202 |
| GSM6208533 | Rat_APAP_03h_2 | tissue: liver strain: Sprague-Dawley Sex: male treatment: 1000 mg/kg acetamnophen (o.g.) hours after treatment: 3 | 9.420006 |
| GSM6208534 | Rat_APAP_03h_3 | tissue: liver strain: Sprague-Dawley Sex: male treatment: 1000 mg/kg acetamnophen (o.g.) hours after treatment: 3 | 9.470302 |
| GSM6208535 | Rat_APAP_03h_4 | tissue: liver strain: Sprague-Dawley Sex: male treatment: 1000 mg/kg acetamnophen (o.g.) hours after treatment: 3 | 8.749901 |
| GSM6208536 | Rat_APAP_03h_5 | tissue: liver strain: Sprague-Dawley Sex: male treatment: 1000 mg/kg acetamnophen (o.g.) hours after treatment: 3 | 8.354136 |
| GSM6208537 | Rat_APAP_06h_1 | tissue: liver strain: Sprague-Dawley Sex: male treatment: 1000 mg/kg acetamnophen (o.g.) hours after treatment: 6 | 10.237972 |
| GSM6208538 | Rat_APAP_06h_2 | tissue: liver strain: Sprague-Dawley Sex: male treatment: 1000 mg/kg acetamnophen (o.g.) hours after treatment: 6 | 10.131609 |
| GSM6208539 | Rat_APAP_06h_3 | tissue: liver strain: Sprague-Dawley Sex: male treatment: 1000 mg/kg acetamnophen (o.g.) hours after treatment: 6 | 10.077435 |
| GSM6208540 | Rat_APAP_06h_4 | tissue: liver strain: Sprague-Dawley Sex: male treatment: 1000 mg/kg acetamnophen (o.g.) hours after treatment: 6 | 10.413883 |
| GSM6208541 | Rat_APAP_06h_5 | tissue: liver strain: Sprague-Dawley Sex: male treatment: 1000 mg/kg acetamnophen (o.g.) hours after treatment: 6 | 10.049946 |
| GSM6208542 | Rat_APAP_09h_1 | tissue: liver strain: Sprague-Dawley Sex: male treatment: 1000 mg/kg acetamnophen (o.g.) hours after treatment: 9 | 10.450301 |
| GSM6208543 | Rat_APAP_09h_2 | tissue: liver strain: Sprague-Dawley Sex: male treatment: 1000 mg/kg acetamnophen (o.g.) hours after treatment: 9 | 10.109102 |
| GSM6208544 | Rat_APAP_09h_3 | tissue: liver strain: Sprague-Dawley Sex: male treatment: 1000 mg/kg acetamnophen (o.g.) hours after treatment: 9 | 10.020756 |
| GSM6208545 | Rat_APAP_09h_4 | tissue: liver strain: Sprague-Dawley Sex: male treatment: 1000 mg/kg acetamnophen (o.g.) hours after treatment: 9 | 10.617155 |
| GSM6208546 | Rat_APAP_09h_5 | tissue: liver strain: Sprague-Dawley Sex: male treatment: 1000 mg/kg acetamnophen (o.g.) hours after treatment: 9 | 10.877136 |
| GSM6208547 | Rat_APAP_24h_1 | tissue: liver strain: Sprague-Dawley Sex: male treatment: 1000 mg/kg acetamnophen (o.g.) hours after treatment: 24 | 7.035507 |
| GSM6208548 | Rat_APAP_24h_2 | tissue: liver strain: Sprague-Dawley Sex: male treatment: 1000 mg/kg acetamnophen (o.g.) hours after treatment: 24 | 6.520109 |
| GSM6208549 | Rat_APAP_24h_3 | tissue: liver strain: Sprague-Dawley Sex: male treatment: 1000 mg/kg acetamnophen (o.g.) hours after treatment: 24 | 7.37292 |
| GSM6208550 | Rat_APAP_24h_4 | tissue: liver strain: Sprague-Dawley Sex: male treatment: 1000 mg/kg acetamnophen (o.g.) hours after treatment: 24 | 6.363928 |
| GSM6208551 | Rat_APAP_24h_5 | tissue: liver strain: Sprague-Dawley Sex: male treatment: 1000 mg/kg acetamnophen (o.g.) hours after treatment: 24 | 6.169918 |
| ID | GSE232804 |
| Title | EGR3 regulates opioid-related nociception and motivation in male rats |
| Organism | Rattus norvegicus |
| GSM | Sample info | Characteristics | Value |
|---|---|---|---|
| GSM7383519 | ww01_Saline_Saline | tissue: Brain / mPFC pain: Saline drug: Salin | 6.0 |
| GSM7383520 | ww02_Saline_Saline | tissue: Brain / mPFC pain: Saline drug: Saline | 5.0 |
| GSM7383521 | ww03_Saline_Saline | tissue: Brain / mPFC pain: Saline drug: Salin | 8.0 |
| GSM7383522 | ww05_Saline_Saline | tissue: Brain / mPFC pain: Saline drug: Saline | 3.0 |
| GSM7383523 | ww06_Saline_Saline | tissue: Brain / mPFC pain: Saline drug: Salin | 8.0 |
| GSM7383524 | ww07_Saline_Saline | tissue: Brain / mPFC pain: Saline drug: Saline | 4.0 |
| GSM7383525 | ww08_Saline_Saline | tissue: Brain / mPFC pain: Saline drug: Salin | 9.0 |
| GSM7383526 | ww10_Saline_Saline | tissue: Brain / mPFC pain: Saline drug: Saline | 2.0 |
| GSM7383527 | ww12_Saline_OXY | tissue: Brain / mPFC pain: Saline drug: OXY | 6.0 |
| GSM7383528 | ww13_Saline_OXY | tissue: Brain / mPFC pain: Saline drug: OXY | 10.0 |
| GSM7383529 | ww14_Saline_OXY | tissue: Brain / mPFC pain: Saline drug: OXY | 13.0 |
| GSM7383530 | ww15_Saline_OXY | tissue: Brain / mPFC pain: Saline drug: OXY | 9.0 |
| GSM7383531 | ww16_Saline_OXY | tissue: Brain / mPFC pain: Saline drug: OXY | 8.0 |
| GSM7383532 | ww17_Saline_OXY | tissue: Brain / mPFC pain: Saline drug: OXY | 11.0 |
| GSM7383533 | ww18_Saline_OXY | tissue: Brain / mPFC pain: Saline drug: OXY | 16.0 |
| GSM7383534 | ww20_Saline_OXY | tissue: Brain / mPFC pain: Saline drug: OXY | 3.0 |
| GSM7383535 | ww21_CFA_Saline | tissue: Brain / mPFC pain: CFA drug: Saline | 6.0 |
| GSM7383536 | ww22_CFA_Saline | tissue: Brain / mPFC pain: CFA drug: Saline | 4.0 |
| GSM7383537 | ww23_CFA_Saline | tissue: Brain / mPFC pain: CFA drug: Saline | 4.0 |
| GSM7383538 | ww24_CFA_Saline | tissue: Brain / mPFC pain: CFA drug: Saline | 4.0 |
| GSM7383539 | ww26_CFA_Saline | tissue: Brain / mPFC pain: CFA drug: Saline | 5.0 |
| GSM7383540 | ww27_CFA_Saline | tissue: Brain / mPFC pain: CFA drug: Saline | 9.0 |
| GSM7383541 | ww28_CFA_Saline | tissue: Brain / mPFC pain: CFA drug: Saline | 8.0 |
| GSM7383542 | ww30_CFA_Saline | tissue: Brain / mPFC pain: CFA drug: Saline | 4.0 |
| GSM7383543 | ww31_CFA_OXY | tissue: Brain / mPFC pain: CFA drug: OXY | 6.0 |
| GSM7383544 | ww32_CFA_OXY | tissue: Brain / mPFC pain: CFA drug: OXY | 3.0 |
| GSM7383545 | ww34_CFA_OXY | tissue: Brain / mPFC pain: CFA drug: OXY | 12.0 |
| GSM7383546 | ww35_CFA_OXY | tissue: Brain / mPFC pain: CFA drug: OXY | 8.0 |
| GSM7383547 | ww36_CFA_OXY | tissue: Brain / mPFC pain: CFA drug: OXY | 15.0 |
| GSM7383548 | ww37_CFA_OXY | tissue: Brain / mPFC pain: CFA drug: OXY | 7.0 |
| GSM7383549 | ww38_CFA_OXY | tissue: Brain / mPFC pain: CFA drug: OXY | 6.0 |
| GSM7383550 | www09_Saline_Saline | tissue: Brain / mPFC pain: Saline drug: Saline | 7.0 |
| GSM7383551 | www19_Saline_OXY | tissue: Brain / mPFC pain: Saline drug: OXY | 7.0 |
| GSM7383552 | www29_CFA_Saline | tissue: Brain / mPFC pain: CFA drug: Saline | 5.0 |
| GSM7383553 | www33_CFA_OXY | tissue: Brain / mPFC pain: CFA drug: OXY | 12.0 |
| GSM7383554 | www39_CFA_OXY | tissue: Brain / mPFC pain: CFA drug: OXY | 5.0 |
| ID | GSE244436 |
| Title | Similarity and dissimilarity in alteration of gene expression profile associated with inhalational anesthesia between sevoflurane and desflurane |
| Organism | Rattus norvegicus |
| GSM | Sample info | Characteristics | Value |
|---|---|---|---|
| GSM7816143 | Liver, Control for SevoAnes | tissue: liver genotype: wild type treatment: Control for SevoAnes | 2.703367 |
| GSM7816144 | Liver, Anesthetized with sevoflurane for 6 h | tissue: liver genotype: wild type treatment: Anesthetized with sevoflurane for 6 h | 3.388806 |
| GSM7816145 | Liver, Control for DesAnes | tissue: liver genotype: wild type treatment: Control for DesAnes | 2.240947 |
| GSM7816146 | Liver, Anesthetized with desflurane for 6 h | tissue: liver genotype: wild type treatment: Anesthetized with desflurane for 6 h | 3.371498 |
| ID | GSE2982 |
| Title | Effect of inhaled anesthetic to cultured cortical neurons |
| Organism | Rattus norvegicus |
| GSM | Sample info | Characteristics | Value |
|---|---|---|---|
| GSM61779 | Cell Culture Exposure (control1) | Cy3 label;Cy5; | -0.0127 |
| GSM61796 | Cell Culture Exposure (control2) | Cy3; Cy5 | -0.00032 |
| GSM61797 | Cell Culture Exposure (control3) | Cy3; Cy5 | 0.0613 |
| GSM61798 | Cell Culture Exposure (1MAC Halo1) | Cy3; Cy5 | 0.136 |
| GSM61799 | Cell Culture Exposure (1MAC Halo2) | Cy3; Cy5 | -0.00116 |
| GSM61800 | Cell Culture Exposure (1MAC Halo3) | Cy3; Cy5 | -0.0117 |
| GSM61801 | Cell Culture Exposure (3MAC Halo1) | Cy3; Cy5 | 0.0297 |
| GSM61802 | Cell Culture Exposure (3MAC Halo2) | Cy3; Cy5 | -0.0229 |
| GSM61803 | Cell Culture Exposure (3MAC Halo3) | Cy3; Cy5 | -0.00268 |
| GSM61804 | Cell Culture Exposure (3MAC ISO1) | Cy3; Cy5 | 0.0395 |
| GSM61805 | Cell Culture Exposure (3MAC ISO2) | Cy3; Cy5 | 0.0446 |
| GSM61806 | Cell Culture Exposure (3MAC ISO3) | Cy3; Cy5 | 0.0103 |
| ID | GSE48025 |
| Title | Affymetrix Chip Data of the Transcriptome of the Rheumatoid Arthritis Rat Model Treated with Acupuncture (Affymetrix, mRNA, batch1) |
| Organism | Rattus norvegicus |
| GSM | Sample info | Characteristics | Value |
|---|---|---|---|
| GSM1165929 | RAT_NORA_T0_1 | gender: Female tissue: RAT Peripheral blood mononuclear cells strain: Wistar rat subject group: healthy rats before therapy | 5.328012143 |
| GSM1165930 | RAT_NORA_T0_2 | gender: Female tissue: RAT Peripheral blood mononuclear cells strain: Wistar rat subject group: healthy rats before therapy | 5.459821302 |
| GSM1165931 | RAT_RA_T0_1 | gender: Female tissue: RAT Peripheral blood mononuclear cells strain: Wistar rat subject group: RA rats before therapy | 5.507507508 |
| GSM1165932 | RAT_RA_T0_2 | gender: Female tissue: RAT Peripheral blood mononuclear cells strain: Wistar rat subject group: RA rats before therapy | 5.126663244 |
| GSM1165933 | RAT_NORA_1h_1 | gender: Female tissue: RAT Peripheral blood mononuclear cells strain: Wistar rat subject group: healthy rats at 1 hour after therapy | 5.290788646 |
| GSM1165934 | RAT_NORA_1h_2 | gender: Female tissue: RAT Peripheral blood mononuclear cells strain: Wistar rat subject group: healthy rats at 1 hour after therapy | 5.396199593 |
| GSM1165935 | RAT_AP_1h_1 | gender: Female tissue: RAT Peripheral blood mononuclear cells strain: Wistar rat subject group: RA rats after 1 hour acupuncture therapy | 5.566054797 |
| GSM1165936 | RAT_AP_1h_2 | gender: Female tissue: RAT Peripheral blood mononuclear cells strain: Wistar rat subject group: RA rats after 1 hour acupuncture therapy | 5.32634335 |
| GSM1165937 | RAT_MTX_1h_1 | gender: Female tissue: RAT Peripheral blood mononuclear cells strain: Wistar rat subject group: RA rats after 1 hour MTX therapy | 5.137390913 |
| GSM1165938 | RAT_MTX_1h_2 | gender: Female tissue: RAT Peripheral blood mononuclear cells strain: Wistar rat subject group: RA rats after 1 hour MTX therapy | 5.306583697 |
| GSM1165939 | RAT_ANE_1h_1 | gender: Female tissue: RAT Peripheral blood mononuclear cells strain: Wistar rat subject group: RA rats after 1 hour ANE therapy | 6.05443117 |
| GSM1165940 | RAT_ANE_1h_2 | gender: Female tissue: RAT Peripheral blood mononuclear cells strain: Wistar rat subject group: RA rats after 1 hour ANE therapy | 5.550318109 |
| GSM1165941 | RAT_PLA_1h_1 | gender: Female tissue: RAT Peripheral blood mononuclear cells strain: Wistar rat subject group: RA rats after 1 hour placebo therapy | 5.655823996 |
| GSM1165942 | RAT_PLA_1h_2 | gender: Female tissue: RAT Peripheral blood mononuclear cells strain: Wistar rat subject group: RA rats after 1 hour placebo therapy | 5.735641601 |
| GSM1165943 | RAT_NORA_34d_1 | gender: Female tissue: RAT Peripheral blood mononuclear cells strain: Wistar rat subject group: healthy rats at 34 days after therapy | 5.825545176 |
| GSM1165944 | RAT_NORA_34d_2 | gender: Female tissue: RAT Peripheral blood mononuclear cells strain: Wistar rat subject group: healthy rats at 34 days after therapy | 5.424475122 |
| GSM1165945 | RAT_AP_34d_1 | gender: Female tissue: RAT Peripheral blood mononuclear cells strain: Wistar rat subject group: RA rats after 34 days acupuncture therapy | 5.505480295 |
| GSM1165946 | RAT_AP_34d_2 | gender: Female tissue: RAT Peripheral blood mononuclear cells strain: Wistar rat subject group: RA rats after 34 days acupuncture therapy | 5.857629948 |
| GSM1165947 | RAT_MTX_34d_1 | gender: Female tissue: RAT Peripheral blood mononuclear cells strain: Wistar rat subject group: RA rats after 34 days MTX therapy | 5.439233338 |
| GSM1165948 | RAT_MTX_34d_2 | gender: Female tissue: RAT Peripheral blood mononuclear cells strain: Wistar rat subject group: RA rats after 34 days MTX therapy | 5.748074504 |
| GSM1165949 | RAT_ANE_34d_1 | gender: Female tissue: RAT Peripheral blood mononuclear cells strain: Wistar rat subject group: RA rats after 34 days ANE therapy | 5.632710129 |
| GSM1165950 | RAT_ANE_34d_2 | gender: Female tissue: RAT Peripheral blood mononuclear cells strain: Wistar rat subject group: RA rats after 34 days ANE therapy | 5.334142534 |
| GSM1165951 | RAT_PLA_34d_1 | gender: Female tissue: RAT Peripheral blood mononuclear cells strain: Wistar rat subject group: RA rats after 34 days placebo therapy | 5.643628078 |
| GSM1165952 | RAT_PLA_34d_2 | gender: Female tissue: RAT Peripheral blood mononuclear cells strain: Wistar rat subject group: RA rats after 34 days placebo therapy | 5.784837246 |
| ID | GSE53897 |
| Title | Genome-wide analysis of dorsal root ganglion (DRG) gene expression after morphine or oxycodone treatment |
| Organism | Rattus norvegicus |
| GSM | Sample info | Characteristics | Value |
|---|---|---|---|
| GSM1303240 | DRG RVM1 | strain: sprague-dawley age: 3 months tissue: dorsal root ganglion | 6.835965 |
| GSM1303241 | DRG RVM2 | strain: sprague-dawley age: 3 months tissue: dorsal root ganglion | 7.022257 |
| GSM1303242 | DRG RVM3 | strain: sprague-dawley age: 3 months tissue: dorsal root ganglion | 6.992416 |
| GSM1303243 | DRG RVM7 | strain: sprague-dawley age: 3 months tissue: dorsal root ganglion | 6.912931 |
| GSM1303244 | DRG RVOx2 | strain: sprague-dawley age: 3 months tissue: dorsal root ganglion | 6.910996 |
| GSM1303245 | DRG RVOx3 | strain: sprague-dawley age: 3 months tissue: dorsal root ganglion | 7.143358 |
| GSM1303246 | DRG RVOx5 | strain: sprague-dawley age: 3 months tissue: dorsal root ganglion | 7.068334 |
| GSM1303247 | DRG RVOx7 | strain: sprague-dawley age: 3 months tissue: dorsal root ganglion | 6.96811 |
| GSM1303248 | DRG RVS4 | strain: sprague-dawley age: 3 months tissue: dorsal root ganglion | 6.938422 |
| GSM1303249 | DRG RVS5 | strain: sprague-dawley age: 3 months tissue: dorsal root ganglion | 6.752951 |
| GSM1303250 | DRG RVS6 | strain: sprague-dawley age: 3 months tissue: dorsal root ganglion | 6.973543 |
| GSM1303251 | DRG RVS7 | strain: sprague-dawley age: 3 months tissue: dorsal root ganglion | 6.983874 |
| GSM1303252 | DRG RSM1 | strain: sprague-dawley age: 3 months tissue: dorsal root ganglion | 7.032079 |
| GSM1303253 | DRG RSM2 | strain: sprague-dawley age: 3 months tissue: dorsal root ganglion | 7.239492 |
| GSM1303254 | DRG RSM4 | strain: sprague-dawley age: 3 months tissue: dorsal root ganglion | 7.251098 |
| GSM1303255 | DRG RSM5 | strain: sprague-dawley age: 3 months tissue: dorsal root ganglion | 7.143358 |
| GSM1303256 | DRG RSOx1 | strain: sprague-dawley age: 3 months tissue: dorsal root ganglion | 6.88171 |
| GSM1303257 | DRG RSOx2 | strain: sprague-dawley age: 3 months tissue: dorsal root ganglion | 6.828721 |
| GSM1303258 | DRG RSOx3 | strain: sprague-dawley age: 3 months tissue: dorsal root ganglion | 7.124255 |
| GSM1303259 | DRG RSOx4 | strain: sprague-dawley age: 3 months tissue: dorsal root ganglion | 7.035951 |
| GSM1303260 | DRG RSS1 | strain: sprague-dawley age: 3 months tissue: dorsal root ganglion | 6.8679 |
| GSM1303261 | DRG RSS2 | strain: sprague-dawley age: 3 months tissue: dorsal root ganglion | 6.872558 |
| GSM1303262 | DRG RSS3 | strain: sprague-dawley age: 3 months tissue: dorsal root ganglion | 7.102124 |
| GSM1303263 | DRG RSS6 | strain: sprague-dawley age: 3 months tissue: dorsal root ganglion | 7.09931 |
| ID | GSE55573 |
| Title | Using DNA microarray to screen intracellular signal pathways of hypoglycemic activity by electroacupuncture of Zusanli (ST36) acupoints in streptozotocin-induced rats with diabetes |
| Organism | Rattus norvegicus |
| GSM | Sample info | Characteristics | Value |
|---|---|---|---|
| GSM1339443 | Mock skeletal muscle | strain: Wistar age: 8-10 week-old gender: Male | 529.7888 |
| GSM1339444 | EA (electroacupuncture) skeletal muscle | strain: Wistar age: 8-10 week-old gender: Male | 986.7829 |
| ID | GSE58456 |
| Title | Affymetrix Chip Data of the Transcriptome of the Rheumatoid Arthritis Rat Model Treated with Acupuncture (Affymetrix, mRNA, batch 2) |
| Organism | Rattus norvegicus |
| GSM | Sample info | Characteristics | Value |
|---|---|---|---|
| GSM1693996 | Peripheral blood mononuclear cells from NORA before therapy, replicate 1 | strain/background: Wistar gender: female cell type: peripheral blood mononuclear cells subject group: healthy rats before therapy | 141.1698869 |
| GSM1693997 | Peripheral blood mononuclear cells from NORA before therapy, replicate 2 | strain/background: Wistar gender: female cell type: peripheral blood mononuclear cells subject group: healthy rats before therapy | 59.00393939 |
| GSM1693998 | Peripheral blood mononuclear cells from NORA before therapy, replicate 3 | strain/background: Wistar gender: female cell type: peripheral blood mononuclear cells subject group: healthy rats before therapy | 283.5927414 |
| GSM1693999 | Peripheral blood mononuclear cells from RA before therapy, replicate 1 | strain/background: Wistar gender: female cell type: peripheral blood mononuclear cells subject group: rheumatoid arthritis rats before therapy | 88.41268485 |
| GSM1694000 | Peripheral blood mononuclear cells from RA before therapy, replicate 2 | strain/background: Wistar gender: female cell type: peripheral blood mononuclear cells subject group: rheumatoid arthritis rats before therapy | 161.1639923 |
| GSM1694001 | Peripheral blood mononuclear cells from HAP after 34 days acupuncture therapy, replicate 1 | strain/background: Wistar gender: female cell type: peripheral blood mononuclear cells subject group: healthy rats after 34 days acupuncture therapy | 135.7287197 |
| GSM1694002 | Peripheral blood mononuclear cells from HAP after 34 days acupuncture therapy, replicate 2 | strain/background: Wistar gender: female cell type: peripheral blood mononuclear cells subject group: healthy rats after 34 days acupuncture therapy | 136.8425599 |
| GSM1694003 | Peripheral blood mononuclear cells from HAP after 34 days acupuncture therapy, replicate 3 | strain/background: Wistar gender: female cell type: peripheral blood mononuclear cells subject group: healthy rats after 34 days acupuncture therapy | 86.16182332 |
| GSM1694004 | Peripheral blood mononuclear cells from AP after 34 days acupuncture therapy, replicate 1 | strain/background: Wistar gender: female cell type: peripheral blood mononuclear cells subject group: rheumatoid arthritis rats after 34 days acupuncture therapy | 111.073864 |
| GSM1694005 | Peripheral blood mononuclear cells from AP after 34 days acupuncture therapy, replicate 2 | strain/background: Wistar gender: female cell type: peripheral blood mononuclear cells subject group: rheumatoid arthritis rats after 34 days acupuncture therapy | 111.7362877 |
| GSM1694006 | Peripheral blood mononuclear cells from AP after 34 days acupuncture therapy, replicate 3 | strain/background: Wistar gender: female cell type: peripheral blood mononuclear cells subject group: rheumatoid arthritis rats after 34 days acupuncture therapy | 46.688156 |
| GSM1694007 | Peripheral blood mononuclear cells from MTXAP after 34 days MTX&acupuncture therapy, replicate 1 | strain/background: Wistar gender: female cell type: peripheral blood mononuclear cells subject group: rheumatoid arthritis rats after 34 days methotrexate & acupuncture therapy | 112.4768003 |
| GSM1694008 | Peripheral blood mononuclear cells from MTXAP after 34 days MTX&acupuncture therapy, replicate 2 | strain/background: Wistar gender: female cell type: peripheral blood mononuclear cells subject group: rheumatoid arthritis rats after 34 days methotrexate & acupuncture therapy | 120.8628239 |
| GSM1694009 | Peripheral blood mononuclear cells from MTXAP after 34 days MTX&acupuncture therapy, replicate 3 | strain/background: Wistar gender: female cell type: peripheral blood mononuclear cells subject group: rheumatoid arthritis rats after 34 days methotrexate & acupuncture therapy | 293.9065243 |
| ID | GSE58460 |
| Title | Rheumatoid Arthritis Rat Model Treated with Acupuncture |
| Organism | Rattus norvegicus |
| GSM | Sample info | Characteristics | Value |
|---|---|---|---|
| GSM1165929 | RAT_NORA_T0_1 | gender: Female tissue: RAT Peripheral blood mononuclear cells strain: Wistar rat subject group: healthy rats before therapy | 5.328012143 |
| GSM1165930 | RAT_NORA_T0_2 | gender: Female tissue: RAT Peripheral blood mononuclear cells strain: Wistar rat subject group: healthy rats before therapy | 5.459821302 |
| GSM1165931 | RAT_RA_T0_1 | gender: Female tissue: RAT Peripheral blood mononuclear cells strain: Wistar rat subject group: RA rats before therapy | 5.507507508 |
| GSM1165932 | RAT_RA_T0_2 | gender: Female tissue: RAT Peripheral blood mononuclear cells strain: Wistar rat subject group: RA rats before therapy | 5.126663244 |
| GSM1165933 | RAT_NORA_1h_1 | gender: Female tissue: RAT Peripheral blood mononuclear cells strain: Wistar rat subject group: healthy rats at 1 hour after therapy | 5.290788646 |
| GSM1165934 | RAT_NORA_1h_2 | gender: Female tissue: RAT Peripheral blood mononuclear cells strain: Wistar rat subject group: healthy rats at 1 hour after therapy | 5.396199593 |
| GSM1165935 | RAT_AP_1h_1 | gender: Female tissue: RAT Peripheral blood mononuclear cells strain: Wistar rat subject group: RA rats after 1 hour acupuncture therapy | 5.566054797 |
| GSM1165936 | RAT_AP_1h_2 | gender: Female tissue: RAT Peripheral blood mononuclear cells strain: Wistar rat subject group: RA rats after 1 hour acupuncture therapy | 5.32634335 |
| GSM1165937 | RAT_MTX_1h_1 | gender: Female tissue: RAT Peripheral blood mononuclear cells strain: Wistar rat subject group: RA rats after 1 hour MTX therapy | 5.137390913 |
| GSM1165938 | RAT_MTX_1h_2 | gender: Female tissue: RAT Peripheral blood mononuclear cells strain: Wistar rat subject group: RA rats after 1 hour MTX therapy | 5.306583697 |
| GSM1165939 | RAT_ANE_1h_1 | gender: Female tissue: RAT Peripheral blood mononuclear cells strain: Wistar rat subject group: RA rats after 1 hour ANE therapy | 6.05443117 |
| GSM1165940 | RAT_ANE_1h_2 | gender: Female tissue: RAT Peripheral blood mononuclear cells strain: Wistar rat subject group: RA rats after 1 hour ANE therapy | 5.550318109 |
| GSM1165941 | RAT_PLA_1h_1 | gender: Female tissue: RAT Peripheral blood mononuclear cells strain: Wistar rat subject group: RA rats after 1 hour placebo therapy | 5.655823996 |
| GSM1165942 | RAT_PLA_1h_2 | gender: Female tissue: RAT Peripheral blood mononuclear cells strain: Wistar rat subject group: RA rats after 1 hour placebo therapy | 5.735641601 |
| GSM1165943 | RAT_NORA_34d_1 | gender: Female tissue: RAT Peripheral blood mononuclear cells strain: Wistar rat subject group: healthy rats at 34 days after therapy | 5.825545176 |
| GSM1165944 | RAT_NORA_34d_2 | gender: Female tissue: RAT Peripheral blood mononuclear cells strain: Wistar rat subject group: healthy rats at 34 days after therapy | 5.424475122 |
| GSM1165945 | RAT_AP_34d_1 | gender: Female tissue: RAT Peripheral blood mononuclear cells strain: Wistar rat subject group: RA rats after 34 days acupuncture therapy | 5.505480295 |
| GSM1165946 | RAT_AP_34d_2 | gender: Female tissue: RAT Peripheral blood mononuclear cells strain: Wistar rat subject group: RA rats after 34 days acupuncture therapy | 5.857629948 |
| GSM1165947 | RAT_MTX_34d_1 | gender: Female tissue: RAT Peripheral blood mononuclear cells strain: Wistar rat subject group: RA rats after 34 days MTX therapy | 5.439233338 |
| GSM1165948 | RAT_MTX_34d_2 | gender: Female tissue: RAT Peripheral blood mononuclear cells strain: Wistar rat subject group: RA rats after 34 days MTX therapy | 5.748074504 |
| GSM1165949 | RAT_ANE_34d_1 | gender: Female tissue: RAT Peripheral blood mononuclear cells strain: Wistar rat subject group: RA rats after 34 days ANE therapy | 5.632710129 |
| GSM1165950 | RAT_ANE_34d_2 | gender: Female tissue: RAT Peripheral blood mononuclear cells strain: Wistar rat subject group: RA rats after 34 days ANE therapy | 5.334142534 |
| GSM1165951 | RAT_PLA_34d_1 | gender: Female tissue: RAT Peripheral blood mononuclear cells strain: Wistar rat subject group: RA rats after 34 days placebo therapy | 5.643628078 |
| GSM1165952 | RAT_PLA_34d_2 | gender: Female tissue: RAT Peripheral blood mononuclear cells strain: Wistar rat subject group: RA rats after 34 days placebo therapy | 5.784837246 |
| GSM1412003 | RAT_NORA_T0_1 | strain: Wistar gender: Female tissue: RAT Peripheral blood mononuclear cells | |
| GSM1412004 | RAT_NORA_T0_2 | strain: Wistar gender: Female tissue: RAT Peripheral blood mononuclear cells | |
| GSM1412005 | RAT_RA_T0_1 | strain: Wistar gender: Female tissue: RAT Peripheral blood mononuclear cells | |
| GSM1412006 | RAT_RA_T0_2 | strain: Wistar gender: Female tissue: RAT Peripheral blood mononuclear cells | |
| GSM1412007 | RAT_NORA_1h_1 | strain: Wistar gender: Female tissue: RAT Peripheral blood mononuclear cells | |
| GSM1412008 | RAT_NORA_1h_2 | strain: Wistar gender: Female tissue: RAT Peripheral blood mononuclear cells | |
| GSM1412009 | RAT_AP_1h_1 | strain: Wistar gender: Female tissue: RAT Peripheral blood mononuclear cells | |
| GSM1412010 | RAT_AP_1h_2 | strain: Wistar gender: Female tissue: RAT Peripheral blood mononuclear cells | |
| GSM1412011 | RAT_MTX_1h_1 | strain: Wistar gender: Female tissue: RAT Peripheral blood mononuclear cells | |
| GSM1412012 | RAT_MTX_1h_2 | strain: Wistar gender: Female tissue: RAT Peripheral blood mononuclear cells | |
| GSM1412013 | RAT_ANE_1h_1 | strain: Wistar gender: Female tissue: RAT Peripheral blood mononuclear cells | |
| GSM1412014 | RAT_ANE_1h_2 | strain: Wistar gender: Female tissue: RAT Peripheral blood mononuclear cells | |
| GSM1412015 | RAT_PLA_1h_1 | strain: Wistar gender: Female tissue: RAT Peripheral blood mononuclear cells | |
| GSM1412016 | RAT_PLA_1h_2 | strain: Wistar gender: Female tissue: RAT Peripheral blood mononuclear cells | |
| GSM1412017 | RAT_NORA_34d_1 | strain: Wistar gender: Female tissue: RAT Peripheral blood mononuclear cells | |
| GSM1412018 | RAT_NORA_34d_2 | strain: Wistar gender: Female tissue: RAT Peripheral blood mononuclear cells | |
| GSM1412019 | RAT_AP_34d_1 | strain: Wistar gender: Female tissue: RAT Peripheral blood mononuclear cells | |
| GSM1412020 | RAT_AP_34d_2 | strain: Wistar gender: Female tissue: RAT Peripheral blood mononuclear cells | |
| GSM1412021 | RAT_MTX_34d_1 | strain: Wistar gender: Female tissue: RAT Peripheral blood mononuclear cells | |
| GSM1412022 | RAT_MTX_34d_2 | strain: Wistar gender: Female tissue: RAT Peripheral blood mononuclear cells | |
| GSM1412023 | RAT_ANE_34d_1 | strain: Wistar gender: Female tissue: RAT Peripheral blood mononuclear cells | |
| GSM1412024 | RAT_ANE_34d_2 | strain: Wistar gender: Female tissue: RAT Peripheral blood mononuclear cells | |
| GSM1412025 | RAT_PLA_34d_1 | strain: Wistar gender: Female tissue: RAT Peripheral blood mononuclear cells | |
| GSM1412026 | RAT_PLA_34d_2 | strain: Wistar gender: Female tissue: RAT Peripheral blood mononuclear cells | |
| GSM1412027 | RAT_RA_T0_1 | strain: Wistar gender: Female tissue: RAT Sub-epidermidis muscle tissue | |
| GSM1412028 | RAT_RA_T0_2 | strain: Wistar gender: Female tissue: RAT Sub-epidermidis muscle tissue | |
| GSM1412029 | RAT_AP_1h_1 | strain: Wistar gender: Female tissue: RAT Sub-epidermidis muscle tissue | |
| GSM1412030 | RAT_AP_1h_2 | strain: Wistar gender: Female tissue: RAT Sub-epidermidis muscle tissue | |
| GSM1412031 | RAT_PLA_1h_1 | strain: Wistar gender: Female tissue: RAT Sub-epidermidis muscle tissue | |
| GSM1412032 | RAT_PLA_1h_2 | strain: Wistar gender: Female tissue: RAT Sub-epidermidis muscle tissue | |
| GSM1412033 | RAT_AP_34d_1 | strain: Wistar gender: Female tissue: RAT Sub-epidermidis muscle tissue | |
| GSM1412034 | RAT_AP_34d_2 | strain: Wistar gender: Female tissue: RAT Sub-epidermidis muscle tissue | |
| GSM1412035 | RAT_PLA_34d_1 | strain: Wistar gender: Female tissue: RAT Sub-epidermidis muscle tissue | |
| GSM1412036 | RAT_PLA_34d_2 | strain: Wistar gender: Female tissue: RAT Sub-epidermidis muscle tissue | |
| GSM1693996 | Peripheral blood mononuclear cells from NORA before therapy, replicate 1 | strain/background: Wistar gender: female cell type: peripheral blood mononuclear cells subject group: healthy rats before therap | 141.1698869 |
| GSM1693997 | Peripheral blood mononuclear cells from NORA before therapy, replicate 2 | strain/background: Wistar gender: female cell type: peripheral blood mononuclear cells subject group: healthy rats before therapy | 59.00393939 |
| GSM1693998 | Peripheral blood mononuclear cells from NORA before therapy, replicate 3 | strain/background: Wistar gender: female cell type: peripheral blood mononuclear cells subject group: healthy rats before therapy | 283.5927414 |
| GSM1693999 | Peripheral blood mononuclear cells from RA before therapy, replicate 1 | strain/background: Wistar gender: female cell type: peripheral blood mononuclear cells subject group: rheumatoid arthritis rats before therapy | 88.41268485 |
| GSM1694000 | Peripheral blood mononuclear cells from RA before therapy, replicate 2 | strain/background: Wistar gender: female cell type: peripheral blood mononuclear cells subject group: rheumatoid arthritis rats before therapy | 161.1639923 |
| GSM1694001 | Peripheral blood mononuclear cells from HAP after 34 days acupuncture therapy, replicate 1 | strain/background: Wistar gender: female cell type: peripheral blood mononuclear cells subject group: healthy rats after 34 days acupuncture therapy | 135.7287197 |
| GSM1694002 | Peripheral blood mononuclear cells from HAP after 34 days acupuncture therapy, replicate 2 | strain/background: Wistar gender: female cell type: peripheral blood mononuclear cells subject group: healthy rats after 34 days acupuncture therap | 136.8425599 |
| GSM1694003 | Peripheral blood mononuclear cells from HAP after 34 days acupuncture therapy, replicate 3 | strain/background: Wistar gender: female cell type: peripheral blood mononuclear cells subject group: healthy rats after 34 days acupuncture therapy | 86.16182332 |
| GSM1694004 | Peripheral blood mononuclear cells from AP after 34 days acupuncture therapy, replicate 1 | strain/background: Wistar gender: female cell type: peripheral blood mononuclear cells subject group: rheumatoid arthritis rats after 34 days acupuncture therapy | 111.073864 |
| GSM1694005 | Peripheral blood mononuclear cells from AP after 34 days acupuncture therapy, replicate 2 | strain/background: Wistar gender: female cell type: peripheral blood mononuclear cells subject group: rheumatoid arthritis rats after 34 days acupuncture therapy | 111.7362877 |
| GSM1694006 | Peripheral blood mononuclear cells from AP after 34 days acupuncture therapy, replicate 3 | strain/background: Wistar gender: female cell type: peripheral blood mononuclear cells subject group: rheumatoid arthritis rats after 34 days acupuncture therapy | 46.688156 |
| GSM1694007 | Peripheral blood mononuclear cells from MTXAP after 34 days MTX&acupuncture therapy, replicate 1 | strain/background: Wistar gender: female cell type: peripheral blood mononuclear cells subject group: rheumatoid arthritis rats after 34 days methotrexate & acupuncture therapy | 112.4768003 |
| GSM1694008 | Peripheral blood mononuclear cells from MTXAP after 34 days MTX&acupuncture therapy, replicate 2 | strain/background: Wistar gender: female cell type: peripheral blood mononuclear cells subject group: rheumatoid arthritis rats after 34 days methotrexate & acupuncture therapy | 120.8628239 |
| GSM1694009 | Peripheral blood mononuclear cells from MTXAP after 34 days MTX&acupuncture therapy, replicate 3 | strain/background: Wistar gender: female cell type: peripheral blood mononuclear cells subject group: rheumatoid arthritis rats after 34 days methotrexate & acupuncture therapy | 293.9065243 |
| ID | GSE8911 |
| Title | Skeletal muscle after fine needle stimulation |
| Organism | Rattus norvegicus |
| GSM | Sample info | Characteristics | Value |
|---|---|---|---|
| GSM225891 | Skeletal muscle sample from fine needle-stimulated hindlimb | Strain: Lewis, Gender: Male, Body Weight: 275g, Tissue: Skeletal muscle sample from fine nnedle-stimulated hindlimb | 520.525 |
| GSM225892 | Skeletal muscle sample from control hindlimb | Strain: Lewis, Gender: Male, Body weight: 275g, Tissue: skeletal muscle sample from non fine needle-stimulated hindlimb | 224.659 |
